Home Cart 0 Sign in  
X

[ CAS No. 19493-45-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 19493-45-9
Chemical Structure| 19493-45-9
Chemical Structure| 19493-45-9
Structure of 19493-45-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 19493-45-9 ]

Related Doc. of [ 19493-45-9 ]

Alternatived Products of [ 19493-45-9 ]

Product Details of [ 19493-45-9 ]

CAS No. :19493-45-9 MDL No. :MFCD05982009
Formula : C9H6ClN Boiling Point : -
Linear Structure Formula :- InChI Key :CPCMFADZMOYDSZ-UHFFFAOYSA-N
M.W : 163.60 Pubchem ID :640968
Synonyms :

Calculated chemistry of [ 19493-45-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.75
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.0
Log Po/w (XLOGP3) : 3.06
Log Po/w (WLOGP) : 2.89
Log Po/w (MLOGP) : 2.15
Log Po/w (SILICOS-IT) : 3.13
Consensus Log Po/w : 2.64

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.45
Solubility : 0.0574 mg/ml ; 0.000351 mol/l
Class : Soluble
Log S (Ali) : -3.0
Solubility : 0.165 mg/ml ; 0.00101 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.31
Solubility : 0.00807 mg/ml ; 0.0000493 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 19493-45-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 19493-45-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 19493-45-9 ]
  • Downstream synthetic route of [ 19493-45-9 ]

[ 19493-45-9 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 2
  • [ 67-66-3 ]
  • [ 121-69-7 ]
  • [ 91-22-5 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 3
  • [ 7742-73-6 ]
  • [ 19493-45-9 ]
YieldReaction ConditionsOperation in experiment
24% With phosphorus; hydrogen iodide In water; acetic acid for 24 h; Reflux A mixture of 1,3-dichloroisoquinoline (5.00 g, 25.2 mmol), red phosphorus, (1.72 g, 55.5 mmol), and hydriodic acid (10.5 mL, 58.1 mmol) in acetic acid (25 mL) was heated to reflux for 24 hours. The reaction mixture was cooled and poured onto ice, and the resulting solution brought to pΗ 7 by the addition of ION aqueous sodium hydroxide. The solution was extracted with dichloromethane (2 x 50 mL), and the organic layers concentrated. The residue was purified by silica gel chromatography (elution with 10percentEtOAc/hexanes) to provide 1.01 g (24percent) of the title compound. MS (DCIZNH3) mZz 164 (M+H)+.
24% With phosphorus; hydrogen iodide In water; acetic acid for 24 h; Reflux A mixture of 1,3-dichloroisoquinoline (5.00 g, 25.2 mmol), red phosphorus, (1.72 g, 55.5 mmol), and hydriodic acid (10.5 mL, 58.1 mmol) in acetic acid (25 mL) was heated to reflux for 24 hours. The reaction mixture was cooled and poured onto ice, and the resulting solution brought to pΗ 7 by the addition of ION aqueous sodium hydroxide. The solution was extracted with dichloromethane (2 x 50 mL), and the organic layers concentrated. The residue was purified by silica gel chromatography (elution with 10percentEtOAc/hexanes) to provide 1.01 g (24percent) of the title compound. MS (DCIZNH3) mZz 164 (M+H)+.
23%
Stage #1: With hydrogenchloride; tin; acetic acid In water at 55 - 60℃; for 3 h;
Stage #2: With ammonia In water
EXAMPLE 60C
3-chloroisoquinoline
The product from Example 60B (6.73 g, 33.8 mmol) was suspended in glacial acetic acid (37 mL) and concentrated HCl (13 mL), treated with tin powder (12.1 g, 101.9 mmol), and heated at 55-60° C. for 3 hours with stirring.
The mixture was allowed to cool to room temperature and the precipitated tin salts were removed by filtration through Celite.
The filtrate was basified to pH 9 with concentrated NH4OH and then extracted with ethyl acetate.
The organic extracts were combined, washed with saturated NaHCO3 solution, dried over Na2SO4, and concentrated under reduced pressure to provide the title compound as a gummy yellow residue (1.28 g, 23percent).
Reference: [1] Patent: WO2010/45401, 2010, A1, . Location in patent: Page/Page column 88
[2] Patent: WO2010/45402, 2010, A1, . Location in patent: Page/Page column 87
[3] Patent: US2005/113576, 2005, A1, . Location in patent: Page/Page column 30
[4] Chemische Berichte, 1886, vol. 19, p. 1655,2356
[5] Chemische Berichte, 1886, vol. 19, p. 1655,2356
[6] Journal of the Chemical Society, 1948, p. 777,781
[7] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
[8] Patent: US4409017, 1983, A,
[9] Patent: WO2010/127855, 2010, A1, . Location in patent: Page/Page column 136; 137
  • 4
  • [ 7742-73-6 ]
  • [ 119-65-3 ]
  • [ 19493-45-9 ]
YieldReaction ConditionsOperation in experiment
71% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium tetrahydroborate; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at 25℃; for 2.5 h; Inert atmosphere General procedure: PdCl2(dppf), PdCl2(tbpf) and (A.caPhos)PdCl2. A mixture of the halogenated heterocycle (0.66 mmol) in anhydrous THF (13.2 mL) was degassed by bubbling argon for few minutes. Then, PdCl2(dppf) (27.0 mg, 0.033 mmol, 5.0 molpercent), TMEDA (0.130 g, 1.12 mmol, 1.7 equiv) and finally NaBH4 (42.4 mg, 1.12 mmol, 1.7 equiv) were introduced in sequence. The mixture was stirred at room temperature under argon for the proper time and then worked up as described above.
Reference: [1] Journal of Molecular Catalysis A: Chemical, 2014, vol. 393, p. 191 - 209
  • 5
  • [ 25475-67-6 ]
  • [ 19493-45-9 ]
YieldReaction ConditionsOperation in experiment
51% With hydrogenchloride; sodium nitrite In water at 0 - 20℃; for 3.08333 h; Synthesis 4-1 -A 3-Chloroisoquinoline 3-Aminoisoquinoline (1.44 g, 10 mmol) was suspended in 10M HCI (5 mL) and cooled to 0°C. Sodium nitrite (689 mg, 10 mmol) was added in portions over 5 minutes. The reaction mixture was stirred at 0°C for 2 hours and allowed to warm to room temperature over 1 hour. The reaction mixture was added carefully to saturated NaHCO3 solution (200 mL) and extracted into ethyl acetate. The insoluble byproduct was removed by filtration and the aqueous layer was re-extracted into ethyl acetate. The combined organics were washed with water and brine, dried (Na2SO4) and concentrated to a brown oil which solidified on standing. Flash chromatography on silica, eluting with dichloromethane, gave the title compound as a white solid (827 mg, 5.05 mmol, 51percent). 1H <n="96"/>NMR (Cl6-DMSO, 400 MHz) δ 9.12 (s, 1 H), 8.41 (s, 1 H), 8.12 (dd, 1 H, J = 7.5, 1.0 Hz), 7.93-7.90 (m, 1 H), 7.84-7.80 (m, 1 H), 7.74-7.70 (m, 1 H). LCMS (1) Rt = 1.79min; m/z (ESI+) 164 (MH+).
Reference: [1] Patent: WO2009/103966, 2009, A1, . Location in patent: Page/Page column 93-94
  • 6
  • [ 7742-73-6 ]
  • [ 7440-31-5 ]
  • [ 19493-45-9 ]
Reference: [1] Patent: US2003/158188, 2003, A1,
[2] Patent: US6933311, 2005, B2,
[3] Patent: US2004/157849, 2004, A1,
  • 7
  • [ 89-51-0 ]
  • [ 19493-45-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
  • 8
  • [ 4456-77-3 ]
  • [ 19493-45-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
  • 9
  • [ 824-72-6 ]
  • [ 19493-45-9 ]
Reference: [1] Patent: US2004/157849, 2004, A1,
  • 10
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 11
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
  • [ 100-47-0 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 12
  • [ 67-66-3 ]
  • [ 121-69-7 ]
  • [ 91-22-5 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 13
  • [ 19493-45-9 ]
  • [ 25475-67-6 ]
Reference: [1] Journal of the Chemical Society, 1956, p. 4191,4205
  • 14
  • [ 19493-45-9 ]
  • [ 58142-49-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
[2] Patent: WO2015/188368, 2015, A1,
[3] Patent: WO2017/69980, 2017, A1,
[4] Patent: US2004/157849, 2004, A1,
[5] Patent: US3930837, 1976, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 19493-45-9 ]

Chlorides

Chemical Structure| 15679-03-5

[ 15679-03-5 ]

6-Chlorophenanthridine

Similarity: 0.82

Chemical Structure| 23616-33-3

[ 23616-33-3 ]

2-Chloro-1,6-naphthyridine

Similarity: 0.81

Chemical Structure| 612-62-4

[ 612-62-4 ]

2-Chloroquinoline

Similarity: 0.81

Chemical Structure| 58142-49-7

[ 58142-49-7 ]

3-Chloroisoquinolin-5-amine

Similarity: 0.77

Chemical Structure| 72093-13-1

[ 72093-13-1 ]

6-Chloro-2,3-dimethylpyridine

Similarity: 0.77

Related Parent Nucleus of
[ 19493-45-9 ]

Isoquinolines

Chemical Structure| 58142-49-7

[ 58142-49-7 ]

3-Chloroisoquinolin-5-amine

Similarity: 0.77

Chemical Structure| 342899-38-1

[ 342899-38-1 ]

3-Chloroisoquinolin-4-amine

Similarity: 0.76

Chemical Structure| 1041423-28-2

[ 1041423-28-2 ]

3-Chloro-6-fluoroisoquinoline

Similarity: 0.75

Chemical Structure| 34784-06-0

[ 34784-06-0 ]

7-Chloroisoquinoline

Similarity: 0.74

Chemical Structure| 62882-02-4

[ 62882-02-4 ]

6-Chloroisoquinoline

Similarity: 0.74